California State Teachers Retirement System (CalSTRS)’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
CP
RCM
SB
DM
LCM
California State Teachers Retirement System (CalSTRS)'s MLYS Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) increased its Mineralys Therapeutics (MLYS) stake by 9.7% in Q2 2026, buying an estimated $163K and bringing the position to 67,221 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1635.
California State Teachers Retirement System (CalSTRS) first reported a position in MLYS in Q1 2023 and has held it in 14 quarters since. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 67,221 shares of Mineralys Therapeutics worth $1.81M as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) bought 5,955 Mineralys Therapeutics shares in Q2 2026, an estimated $163K.
- Mineralys Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1635 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 14 quarters since.
- 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.